1991
DOI: 10.1016/0140-6736(91)93445-f
|View full text |Cite
|
Sign up to set email alerts
|

CD4 lymphocytopenia without HIV in patient with cryptococcal infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Defects in T-cell immunity are a strong risk factor for cryptococcal infections [ 131 ]. Fungal GXM partially inhibits leukocyte migration of many types of cells, including T-cells [ 132 ], synergizing with acquired defects in T-cell immunity by infections with HIV, treatment with chemotherapy or steroids [ 133 , 134 , 135 ] or in the presence of idiopathic CD4 lymphopenia [ 136 ]. Secreted GXM also binds the inhibitory receptor FcγIIB [ 137 ] where it leads to induction of the death receptor FasL, activating apoptosis in activated T-cells via the FasL/Fas pathway through upregulation by JNK and p38 activation [ 138 , 139 , 140 ].…”
Section: Function Follows Form: Capsule Alters Host Immune Responsmentioning
confidence: 99%
“…Defects in T-cell immunity are a strong risk factor for cryptococcal infections [ 131 ]. Fungal GXM partially inhibits leukocyte migration of many types of cells, including T-cells [ 132 ], synergizing with acquired defects in T-cell immunity by infections with HIV, treatment with chemotherapy or steroids [ 133 , 134 , 135 ] or in the presence of idiopathic CD4 lymphopenia [ 136 ]. Secreted GXM also binds the inhibitory receptor FcγIIB [ 137 ] where it leads to induction of the death receptor FasL, activating apoptosis in activated T-cells via the FasL/Fas pathway through upregulation by JNK and p38 activation [ 138 , 139 , 140 ].…”
Section: Function Follows Form: Capsule Alters Host Immune Responsmentioning
confidence: 99%